rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
27	Malignant neoplasm of male breast	C0242787	4	43	3.12639530931e-08	1.9299499642601858e-05	CYP19A1,PGR,AR,ESR1
29	Malignant neoplasm of female breast	C0235653	4	51	7.53679390009e-08	2.0729092208720515e-05	CYP19A1,PGR,AR,ESR1
31	Female Breast Carcinoma	C0007104	4	54	1.00927001867e-07	2.2158684774839172e-05	CYP19A1,PGR,AR,ESR1
32	Carcinoma of Male Breast	C0238033	4	55	1.10917998786e-07	2.28734810578985e-05	CYP19A1,PGR,AR,ESR1
36	Ovarian Failure, Premature	C0085215	6	199	2.00471403811e-07	2.5732666190135812e-05	CYP19A1,CYP3A4,PGR,AR,SRD5A1,ESR1
38	Disorder of endocrine system	C0014130	4	68	3.25336257823e-07	2.716225875625447e-05	CYP19A1,PGR,AR,ESR1
39	Mammographic breast density	C1268717	4	70	3.76561226978e-07	2.7877055039313796e-05	CYP19A1,PGR,AR,ESR1
40	Female infertility	C0021361	4	72	4.33932608845e-07	2.8591851322373122e-05	CYP19A1,PGR,AR,ESR1
43	Uterine neoplasm	C0042138	4	77	6.07881898596e-07	3.073624017155111e-05	CYP19A1,PGR,AR,ESR1
44	Recurrent abortion	C0000809	4	79	6.91190647939e-07	3.1451036454610436e-05	CYP19A1,PGR,AR,ESR1
46	Pregnancy loss	C0156543	4	81	7.8318781882e-07	3.2880629020729096e-05	CYP19A1,PGR,AR,ESR1
47	Invasive Lobular Breast Carcinoma	C0279565	3	36	9.89974909382e-07	3.359542530378842e-05	PGR,AR,ESR1
52	Aortic regurgitation	C0003504	4	92	1.47713944365e-06	3.7169406719085056e-05	CYP19A1,PGR,AR,ESR1
53	Stromal sarcoma	C0206630	3	40	1.52632355999e-06	3.788420300214439e-05	CYP19A1,PGR,ESR1
60	Virilism	C0042755	3	48	3.20940461318e-06	4.288777698355969e-05	CYP19A1,AR,SRD5A1
84	Nerve Sheath Tumors	C0206727	3	54	5.16754294955e-06	6.004288777698356e-05	PGR,AR,ESR1
85	Endometrial Hyperplasia	C0014173	3	54	5.16754294955e-06	6.0757684060042885e-05	PGR,AR,ESR1
86	Precocious puberty	C0034013	4	120	5.47433888398e-06	6.147248034310222e-05	CYP19A1,PGR,SRD5A1,ESR1
89	Depressive Symptoms	C0086132	4	122	5.93538960181e-06	6.36168691922802e-05	CYP19A1,CYP3A4,AR,ESR1
90	Penile hypospadias	C1691215	3	56	5.98283690212e-06	6.433166547533953e-05	AR,SRD5A1,ESR1
91	Thrombophilia	C0398623	4	125	6.68338449328e-06	6.504646175839887e-05	CYP19A1,PGR,SRD5A1,ESR1
94	Infertility associated with multi-tailed spermatozoa and excessive DNA	C0021359	4	128	7.50330021682e-06	6.719085060757685e-05	CYP19A1,PGR,AR,ESR1
100	Breast Fibrocystic Disease	C0016034	3	64	1.02212441754e-05	7.14796283059328e-05	CYP19A1,AR,ESR1
101	Ovarian Diseases	C0029928	5	236	1.02698815154e-05	7.219442458899215e-05	CYP19A1,PGR,AR,SRD5A1,ESR1
120	Decreased fertility in females	C0151639	2	25	1.97380541607e-05	8.577555396711938e-05	CYP19A1,PGR
121	Endometrial Neoplasms	C0014170	5	268	2.10812542687e-05	8.649035025017871e-05	CYP19A1,CYP3A4,PGR,AR,ESR1
133	Stromal Neoplasm	C0879615	3	82	2.73578393387e-05	9.506790564689064e-05	PGR,AR,ESR1
134	Chordoma	C0008487	3	83	2.86982936666e-05	9.578270192994997e-05	PGR,AR,ESR1
135	Bladder neck obstruction	C0005694	2	29	3.11709857609e-05	9.64974982130093e-05	CYP19A1,ESR1
136	Adrenocortical adenoma	C0206667	3	89	3.77759366618e-05	9.721229449606862e-05	CYP19A1,PGR,ESR1
137	Alcohol withdrawal syndrome	C0236663	2	31	3.82309823439e-05	9.792709077912795e-05	CYP19A1,AR
138	Ambiguous genitalia	C0266362	3	90	3.9471353464e-05	9.864188706218729e-05	CYP19A1,AR,SRD5A1
139	Tumor Initiation	C0598935	4	182	4.09702757582e-05	9.935668334524661e-05	CYP19A1,PGR,AR,NCOA1
140	Alopecia of scalp	C0574769	2	32	4.21230297217e-05	0.00010007147962830593	CYP19A1,AR
156	Oestrogen deficiency	C0853662	2	33	4.62662235188e-05	0.00011150822015725518	CYP19A1,ESR1
157	Carpal tunnel syndrome	C0007286	2	33	4.62662235188e-05	0.00011222301644031452	PGR,ESR1
158	Prostatitis	C0497496	2	33	4.62662235188e-05	0.00011293781272337384	AR,SRD5A1
159	Postmenopausal osteoporosis	C0029458	3	95	4.87959867403e-05	0.00011365260900643316	CYP19A1,AR,ESR1
160	Comedone	C0221228	2	34	5.06679034091e-05	0.00011436740528949249	PGR,ESR1
161	Testicular malignant germ cell tumor	C0855197	3	96	5.0838225241e-05	0.00011508220157255183	AR,SRD5A1,ESR1
162	Endometriosis of ovary	C0156344	2	35	5.53354469697e-05	0.00011579699785561116	PGR,ESR1
163	Metastatic Carcinoma	C1384494	2	36	6.02759085107e-05	0.00011651179413867048	PGR,AR
176	Endometrial adenocarcinoma	C1153706	3	103	6.69276032027e-05	0.00012580414581844174	PGR,AR,ESR1
177	Testicular Germ Cell Tumor	C1336708	3	103	6.69276032027e-05	0.00012651894210150108	CYP19A1,AR,ESR1
178	Migraine Disorders	C0149931	5	333	7.06588837863e-05	0.0001272337383845604	CYP19A1,CYP3A4,PGR,AR,ESR1
179	Pregnancy associated hypertension	C0852036	2	38	7.10045616756e-05	0.00012794853466761974	PGR,ESR1
180	High grade serous carcinoma	C0206701	3	105	7.21360867694e-05	0.00012866333095067905	PGR,AR,ESR1
181	Gynecomastia	C0018418	3	105	7.21360867694e-05	0.00012937812723373836	CYP19A1,AR,ESR1
182	Mammary Neoplasms, Experimental	C0024668	4	207	7.54403288477e-05	0.00013009292351679773	PGR,H3F3B,ESR1,NCOA1
183	Prostate cancer stage C	C0280280	2	39	7.6806952414e-05	0.00013080771979985704	PKN1,AR
184	21-hydroxylase deficiency	C1291314	2	40	8.29107824897e-05	0.00013152251608291638	CYP3A4,AR
185	Prostatic Diseases	C0033575	2	40	8.29107824897e-05	0.0001322373123659757	AR,SRD5A1
186	Delayed menarche	C0232939	3	109	8.34305921198e-05	0.00013295210864903504	CYP19A1,AR,ESR1
187	Abnormal circulating gonadotropin level	C4072886	2	41	8.93231057557e-05	0.00013366690493209435	AR,ESR1
188	Uterine Corpus Cancer	C0153574	6	506	8.96124018536e-05	0.0001343817012151537	PKN1,CYP19A1,CYP3A4,PGR,AR,ESR1
189	Malignant neoplasm of endometrium	C0007103	6	506	8.96124018536e-05	0.000135096497498213	PKN1,CYP19A1,CYP3A4,PGR,AR,ESR1
199	Acanthosis nigricans	C0000889	2	42	9.6050768274e-05	0.00014224446032880627	CYP19A1,ESR1
200	Primary malignant neoplasm of brain	C0750979	2	42	9.6050768274e-05	0.0001429592566118656	AR,KDM1A
201	Metastatic Prostate Carcinoma	C0936223	4	224	0.000109359282799	0.00014367405289492495	PKN1,CYP19A1,AR,SRD5A1
202	Pathologic fracture	C0016663	2	44	0.00011047977925	0.0001443888491779843	CYP19A1,ESR1
203	Thromboembolism	C0040038	3	118	0.000113480202307	0.0001451036454610436	CYP3A4,PGR,ESR1
204	Bone necrosis	C0029445	2	45	0.000118194815051	0.00014581844174410295	CYP3A4,ESR1
205	Adolescent idiopathic scoliosis	C0410702	2	45	0.000118194815051	0.00014653323802716226	AR,ESR1
219	Weight Loss Adverse Event	C2911645	2	46	0.000126252629218	0.00015654038598999283	CYP19A1,AR
220	Abnormal epiphyseal ossification	C4021246	2	46	0.000126252629218	0.0001572551822730522	CYP19A1,ESR1
221	Anaplasia	C0002793	4	231	0.000126308618285	0.0001579699785561115	PGR,AR,ESR1,NCOA1
222	Carcinoma, Endometrioid	C0206687	3	123	0.00013321269526	0.00015868477483917085	CYP19A1,PGR,ESR1
223	Premature ovarian failure	C0025322	3	123	0.00013321269526	0.00015939957112223017	CYP19A1,AR,ESR1
224	Spermatogenic failure 3	C1847540	2	47	0.000134659901618	0.0001601143674052895	CYP19A1,AR
225	Male pseudohermaphroditism	C0238395	2	48	0.000143423201893	0.00016082916368834882	AR,SRD5A1
226	Aplasia/hypoplasia of the uterus	C4024640	2	48	0.000143423201893	0.00016154395997140813	AR,ESR1
227	Mesothelioma, malignant	C0025500	5	383	0.000151833331842	0.00016225875625446747	PKN1,CYP3A4,PGR,AR,ESR1
